According to a recent LinkedIn post from Artera, the company is planning to appear on stage at ViVE2026 alongside Hanger, Inc.’s vice president of patient and employee experience, Carrie Davis. The session is described as focusing on the evolution from general interest in artificial intelligence to active deployment of AI agents in patient access.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post highlights that Hanger is portrayed as piloting “unique AI strategies” in collaboration with Artera to deploy agents intended to transform elements of the care experience. For investors, this suggests Artera is positioning its technology as an applied AI solution in healthcare operations, potentially deepening its footprint with enterprise customers and strengthening its use cases in patient-access workflows.
The emphasis on “vision and deep partnership” implies a strategic, rather than purely transactional, relationship with Hanger, which could support longer-term revenue visibility if such collaborations scale. Participation in ViVE2026’s Data Innovation Theater may also increase Artera’s exposure to health systems and digital-health buyers, helping the company compete in a crowded AI-in-healthcare landscape and possibly influencing future pipeline development.